Don Carson and Marc Goodman have joined US Equities Research as Managing Directors in the Industrials and Healthcare sectors of UBS Investment Bank.
Carson will cover Agricultural, Commodity, and Specialty Chemicals. Goodman will cover Specialty Pharmaceuticals and Generics. Carson and Goodman are based in New York and report to David Bleustein, Head of US Equities Research.
Carson joins UBS from Merrill Lynch where he was a top-rated analyst, earning recognition as Institutional Investor’s #1 ranked Chemicals analyst for the past six years. In addition, he ranked first in the 2008 Greenwich Research poll. Previously, Carson worked for JPMorgan.
Goodman joins UBS from Credit Suisse following 12 years at Morgan Stanley. Institutional Investor has recognized him as a top analyst for the last six consecutive years. In 2008, he ranked third team in the Healthcare/Specialty Pharma category.
“Providing our clients with integrated, full-service solutions is the hallmark of US Equities Research,” says David Bleustein, head of US Equities Research. “We are excited to welcome Don and Marc to UBS. Their extensive knowledge and experience in their respective sectors strengthens UBS’s already powerful research offering at a time when client demand for reliable research and creative thinking is intensifying.”
L.D.